PetIQ, Inc. (NASDAQ:PETQ) Shares Sold by Applied Fundamental Research LLC

Applied Fundamental Research LLC lowered its holdings in shares of PetIQ, Inc. (NASDAQ:PETQ) by 64.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 219,076 shares of the company’s stock after selling 405,000 shares during the quarter. PetIQ accounts for about 4.5% of Applied Fundamental Research LLC’s portfolio, making the stock its 10th biggest position. Applied Fundamental Research LLC owned about 0.73% of PetIQ worth $6,741,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Quantbot Technologies LP acquired a new stake in shares of PetIQ during the third quarter worth $283,000. Bank of Montreal Can bought a new position in PetIQ during the 3rd quarter worth about $7,996,000. Centaurus Financial Inc. acquired a new stake in shares of PetIQ in the 3rd quarter valued at about $114,000. Charles Schwab Investment Management Inc. lifted its holdings in shares of PetIQ by 5.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 225,007 shares of the company’s stock valued at $6,923,000 after purchasing an additional 12,172 shares in the last quarter. Finally, Intech Investment Management LLC acquired a new position in shares of PetIQ during the third quarter worth about $280,000. Institutional investors own 94.99% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on PETQ shares. Truist Financial downgraded PetIQ from a “buy” rating to a “hold” rating and upped their price target for the stock from $30.00 to $31.00 in a research report on Thursday, August 8th. William Blair downgraded shares of PetIQ from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 7th.

PetIQ Stock Performance

Shares of NASDAQ PETQ opened at $30.98 on Tuesday. The company has a debt-to-equity ratio of 1.68, a quick ratio of 1.68 and a current ratio of 2.58. The stock has a 50 day moving average price of $30.90 and a 200 day moving average price of $26.58. The stock has a market capitalization of $925.99 million, a PE ratio of 79.44 and a beta of 1.73. PetIQ, Inc. has a 52 week low of $15.09 and a 52 week high of $31.06.

PetIQ Profile

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.